Navigation Links
Little Evidence on Value of Treatments for Autism: Report
Date:8/28/2012

TUESDAY, Aug. 28 (HealthDay News) -- There is just not enough evidence to determine whether or not current treatments actually help adolescents and young adults with autism, researchers report.

"Overall, there is very little evidence in all areas of care for adolescents and young adults with autism, and it is urgent that more rigorous studies be developed and conducted," report senior author Melissa McPheeters, director of Vanderbilt University's Evidence-Based Practice Center, said in a university news release.

Her team reviewed 32 studies published between 1980 and 2011 on therapies for people aged 13 to 30 with autism.

They found some evidence that treatments might boost social skills and educational outcomes such as vocabulary and reading, but the studies were generally small and had limited follow-up.

There was little evidence supporting the use of drug therapy for people with autism in these age groups. The most consistent findings showed that antipsychotic medications might lessen problem behaviors such as irritability and aggression. However, harmful side effects linked to these medications included weight gain and sedation.

Only five studies tested interventions involving work skills training for young people with autism. All of the studies suggested that vocational interventions may be effective for some adolescents and young adults with autism, but the studies also had significant flaws that raised questions about their conclusions.

One expert said the paucity of data on this topic is disheartening.

"Only five studies that address vocation skills were published in the last three decades, and all were of poor quality," said Geraldine Dawson, chief science officer at the advocacy group Autism Speaks. However, "the meager evidence that exists suggests that vocational interventions improve rates of employment, reduce autism symptoms, and [improve] quality of life."

She said more and better data is needed. "Given the huge number of adolescents [with autism] who will be entering adulthood in the next several years, it is crucial that we address this knowledge gap," Dawson said. "There is a great need for research to identify the most effective strategies for helping young people with autism navigate the transition to adulthood successfully."

Autism rates are rising, but much remains to be discovered about treatments, added the researchers, whose review was published by the U.S. Agency for Healthcare Research and Quality. The findings about vocational interventions were published separately in the Aug. 27 issue of the journal Pediatrics.

"There are growing numbers of adolescents and adults with autism in need of substantial support. Without a stronger evidence base, it is very hard to know which interventions will yield the most meaningful outcomes for individuals with autism and their families," Zachary Warren, director of the Vanderbilt Kennedy Center's Treatment and Research Institute for Autism Spectrum Disorders, said in the news release.

More information

Autism Speaks has more about autism treatments.

-- Robert Preidt

SOURCES: Geraldine Dawson, Ph.D., chief science officer, Autism Speaks; Vanderbilt University, news release, Aug. 27, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Little evidence supports autism treatment options in adolescents
2. Milk Thistle of Little Help Against Hepatitis C: Study
3. Kids Born Even a Little Early Have Lower School Scores: Study
4. New federal disclosure law may have little impact on drugs prescribed
5. Too much vitamin D can be as unhealthy as too little
6. OSHAs Safety Tests Protect Workers at Little Cost: Study
7. A Little More Education, a Little Longer Life?
8. Botox Offers Little Relief for Migraine, Study Finds
9. U.S. Spends Too Little on Public Health Initiatives: Report
10. In children born with severe heart defect, surgical management has little effect on neuro outcomes
11. First evidence from humans on how alcohol may boost risk of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Little Evidence on Value of Treatments for Autism: Report
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: